Smith & Nephew, Inc.
Senior Vice President, Global Operations Strategy and Transformation
Smith & Nephew Apr 2015 - Dec 2018
Senior Vice President, Global Process Optimization
Smith & Nephew Jan 2014 - Mar 2015
Vice President, Supply Chain Management
Smith & Nephew Feb 2012 - Dec 2013
Vice President, Commercial Supply Chain
Biogen Idec International Mar 2011 - Mar 2012
Senior Director, Global Commercial Drug Supply
Education:
Boston University 1996 - 1997
Master of Business Administration, Masters, Operations Management
University of Illinois at Urbana - Champaign 1986 - 1990
Bachelors, Bachelor of Science, Chemistry
Skills:
Cross Functional Team Leadership Strategy Medical Devices Supply Chain Management Management Leadership Supply Chain Process Improvement Biotechnology Fda Pharmaceutical Industry Quality System Manufacturing Sap Operations Management Gmp Change Management Business Process Improvement Business Strategy Logistics Six Sigma Product Development Strategic Planning Integration Business Intelligence Erp Product Launch Consulting Enterprise Resource Planning Commercial Operation Procurement Lean Manufacturing Quality Assurance Validation Continuous Improvement Iso 13485 Operational Excellence U.s. Food and Drug Administration Negotiation Capa Sap Products R&D
Thomas Britton - Carmel IN, US Robert Bruns - Carmel IN, US Buddy Cantrell - Fountaintown IN, US Philip Hipskind - New Palestine IN, US Karen Lobb - Indianapolis IN, US James Nixon - Indianapolis IN, US Paul Ornstein - Carmel IN, US Edward Smith - Indianapolis IN, US Hamideh Zarrinmayeh - Carmel IN, US Dennis Zimmerman - Zionsville IN, US Anne Nunes - Andover MA, US James Howbert - Bellevue WA, US
International Classification:
C07D235/02 A61K031/415 A01N043/52
US Classification:
548/304100, 548/310700, 514/393000
Abstract:
This invention provides a series of substituted benzimidazoles which are useful in treating or preventing a condition associated with an excess of neuropeptide Y. This invention also provides methods employing these substituted benzimidazoles as well as pharmaceutical formulations with comprise as an active ingredient one or more of these compounds.
Naphthimidazolyl Neuropeptide Y Receptor Antagonists
This invention provides a series of substituted 1H-naphth�2,3-d!imidazoles which are useful in treating a condition associated with an excess of neuropeptide Y. This invention also provides methods employing these substituted 1H-naphth�2,3-d!imidazoles as well as pharmaceutical formulations with comprise as an active ingredient one or more of these compounds.
Thomas Charles Britton - Carmel IN Robert Frederick Bruns - Carmel IN Buddy Eugene Cantrell - Fountaintown IN Philip Arthur Hipskind - New Palestine IN Karen Lynn Lobb - Indianapolis IN James Arthur Nixon - Indianapolis IN Paul Leslie Ornstein - Carmel IN Edward C. R. Smith - Indianapolis IN Hamideh Zarrinmayeh - Carmel IN Dennis Michael Zimmerman - Zionsville IN Anne Marie Nunes - Andover MA James Jeffry Howbert - Bellevue WA
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
C07D23512 C07D23522 A01N 4352 A61K 31415
US Classification:
5483101
Abstract:
This invention provides a series of substituted benzimidazoles which are useful in treating or preventing a condition associated with an excess of neuropeptide Y. This invention also provides methods employing these substituted benzimidazoles as well as pharmaceutical formulations with comprise as an active ingredient one or more of these compounds.
Dr. Nunes graduated from the Kansas City University of Medicine and Biosciences College of Osteopathic Medicine in 1997. She works in Keizer, OR and specializes in Urgent Care Medicine.